Your browser doesn't support javascript.
The impact of biosafety enhancement on stat laboratory quality metrics: Lessons from the COVID-19 pandemic.
Clin Chim Acta ; 512: 58-62, 2020 Dec 04.
Article in English | MEDLINE | ID: covidwho-956958
ABSTRACT

OBJECTIVE:

It is unclear if implementation of biosafety action plans in response to the COVID-19 pandemic has affected laboratory quality metrics.

METHODS:

This retrospective study used quality data, including turnaround time (TAT) and number/type of unacceptable specimens from a stat laboratory supporting an outpatient medical clinic serving predominantly elderly cancer patients. Four months of data from the height of the COVID-19 pandemic (March-June 2020) were compared to the same months in 2019.

RESULTS:

March-May 2020 test volumes were decreased compared to 2019. June 2020 test volume was slightly increased compared to 2019. TATs in 2020 were similar/ slightly improved compared to the same months in 2019, due to shortened collect to receive and receive to verify TATs. The number and types of unacceptable specimens were similar in 2020 and 2019.

CONCLUSIONS:

Despite the challenges to the system caused by the pandemic, laboratory quality metrics were maintained.
Full text: Available Collection: International databases Database: MEDLINE Type: Article Type of study: Observational study Language: English Journal: Clin Chim Acta Year: 2020

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Collection: International databases Database: MEDLINE Type: Article Type of study: Observational study Language: English Journal: Clin Chim Acta Year: 2020